InvestorsHub Logo
Followers 93
Posts 17841
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Wednesday, 05/26/2021 8:52:04 AM

Wednesday, May 26, 2021 8:52:04 AM

Post# of 194846
Get to Know your RXMD TEAM...

RXMD Armen:
https://securitiesarbitrations.com/finra-files-complaint-fl-broker-dealer/

RXMD Oleg:

https://storage.courtlistener.com/recap/gov.uscourts.flsd.576078/gov.uscourts.flsd.576078.1.0.pdf

https://www.miamiherald.com/news/local/community/miami-dade/article231993317.html

RXMD Fife:
https://www.sec.gov/litigation/complaints/2020/comp24886.pdf

RXMD Jay:

On December 1, 2010 the Company entered into an agreement with Jay Weisberg (our CFO). Pursuant to this agreement, Mr. Weisberg will receive $48,000 per annum, plus $5,000 in stock each quarter; the exact number of shares calculated by dividing the closing price of the Company’s stock on the OTCBB at the end of each quarter. Mr. Weisberg is also a partner in Weisberg Brause, who the Company paid approx. $4,000 to in connection with certain tax related services. In addition, Mr. Weisberg is the Chief Financial Officer of Basis Financial, an investment banking firm which the Company has used to raise funds and which is headed by Mr. Karapetyan a related party.


Jervis:

Mr. Hough was employed by Blaylock Robert Van LLC, RJL Capital Group LLC, NMS Financial Services LLC, Basis Financial LLC, Capital & Credit International, Inc., and Banc of America Investment Services, Inc.

The complaint states that Basis, Karapetyan and Goldfine violated the antifraud rules of federal securities laws by knowingly or recklessly making material misrepresentations, omitting material information and engaging in fraudulent misconduct in the course of their the sale of private placement offerings to investors using the U.S. mail or other instrumentalities of interstate commerce.

Why place someone on Ignore, if you're going to read and respond to the Posts anyway?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News